Page 1585 - Small Animal Internal Medicine, 6th Edition

Index 1557

Enoxaparin Erythrocytosis (Continued) Eucoleus aerophila. see Capillaria spp., C. Familial reflex myoclonus, 1182
arterial thromboembolism in cats in pulmonary hypertension, 116 aerophila Famotidine, 439, 439t, 515t–517t,
treated with, 227b relative, 1368, 1369b Euthyroid sick syndrome, 779–780, 780f Fasciohumoral muscular dystrophy, 151
1255t–1256t
VetBooks.ir Enrofloxacin, 386t–388t, 515t–517t in tetralogy of Fallot, 114 Evans syndrome, 1243–1244 Fat, in veterinary therapeutic diets,
secondary, 1368, 1369b
dosage of, 229
Eutocia, 968–969
Event recording, intermittent, 50–51
904t–906t
bacterial infections treated with,
treatment of, 1369–1370
tumor-associated, 1368
1437t–1438t
Febantel/praziquantel/pyrantel,
271
brucellosis treated with, 965 Erythromycin, 515t–517t, 1437t–1438t Exacerbating event, in laryngeal diseases, Fear-induced aggression, 975
joint disease treated with, 1209t–1210t Erythropoietin, 1353 Exaggerated pseudocyesis, 957 1538–1539
neurologic disorders treated with, chronic kidney disease, 701–702 Excretory urography, 671 Febrile neutropenia, 1279–1280
1185t–1186t Escape complexes, 41–42 Exercise Fecal culture, bacterial, 414
Entamoeba histolytica, 1533t–1535t Escherichia coli, 1533t–1535t diabetes mellitus in dogs managed Fecal digestion tests, 413–414
Enteral diet, 436t Esmolol with, 816–817 Fecal examination
Enteric duplication, 1014 in cats, 90t–91t heart failure effects on, 58 Baermann technique, 1428
Enteric zoonoses, 1532–1539, characteristics of, 94, 94t Exercise intolerance direct smear, 1427
1533t–1535t in dogs, 90t–91t causes of, 1183–1184, 1184b stained smear, 1427–1428, 1428f
Enteritis dosage of, 90t–91t heart failure and, 1 Fecal fat analysis, 413
canine coronaviral, 479 hypertension treated with, 217t lower respiratory tract disorders as Fecal flotation, 413, 1428
canine parvoviral, 476–478, 477b Esomeprazole, 439t, 515t–517t cause of, 283–284 Fecal incontinence, 405
feline coronaviral, 479 Esophageal regurgitation, 392 Exercise-induced collapse, 1183–1184 Fecal sedimentation, 413
feline parvoviral, 478–479 Esophageal sphincter disorders, 1106–1107 Fecal transplantation, 443
Enterococcus, 443 endoscopy of, 426f Exocrine pancreas, 620–643 Feces
Enterocolitis, 1281 lower, 426f Exocrine pancreatic insufficiency, 491, cytologic evaluation of, 415
Enteropathy Esophageal weakness, 418f 636–641 leukocytes in, 415
in Chinese Shar-Peis, 497 acquired, 454 in cats, 638 preservation of, 1429
immunoproliferative, of Basenjis, 497 congenital, 452–454, 453f clinical features of, 638 Feeding tubes
intestinal lymphangiectasia, 495–497, description of, 393, 393b description of, 399, 413, 620, 622t, enterostomy, 437
496f Esophagitis, 455–456 636–641 gastrostomy, 436
protein-losing, 495–498 clinical features of, 455 diet for, 640–641 jejunostomy, 437
in Shiba dogs, 497–498 diagnosis of, 455 drugs for, 640 nasoesophageal, 435
Enterostomy tubes, 437 endoscopy of, 425f folate concentration in, 640 feeding uses of, 437
Enterotoxemia, 475 etiology of, 455 pancreatic enzymes and, 639 placement of, 567f, 567b
Entocort. see Budesonide prognosis for, 456 pathogenesis of, 636–638, 637f–638f orogastric, 435
Environment treatment of, 455–456 prognosis of, 641 pharyngostomy, 436
feline bronchitis caused by, 337 Esophagoscopy, 393, 424–425, 424f treatment of, 640–641 Felbamate (Felbatol), 1104, 1185t–1186t
feline idiopathic cystitis, modifications Esophagostomy tubes, 436 Exocrine pancreatic neoplasia, 641 Feldene. see Piroxicam
for, 727–728, 728b Esophagrams, 416, 417f, 459f Exophthalmos, 1175–1176 Felimazole. see Methimazole
Enzyme-linked immunosorbent assay Esophagus Expectorants, 343 Feline acromegaly, 749–753
alimentary tract disease evaluations, cicatrix of, 459–460 Expectoration, regurgitation versus, clinical features of, 750–751, 751f
414 dysmotility, regurgitation caused by, 391–392 clinical pathology of, 751–752
cryptosporidial antigens, 414 346 Exploratory thoracotomy, 373–374 clinical signs of, 750b
feline leukemia virus detection, foreign objects in, 416–417, 418f, Extracellular fluid, 844f, 915–916 diagnosis of, 752, 752f
1497 458–459, 458f Extrahepatic bile duct obstruction, 526, etiology of, 749–750
Eosinopenia, 1376 imaging of, 416–419 573–574, 573b, 601–603, 601f hyperadrenocorticism versus, 752
Eosinophilia, 1377, 1377b, 1426t indications for, 416–419 in cats, 573–574, 573b insulin-resistant diabetes mellitus
Eosinophilic gastritis, 463 neoplasms of, 460, 460f clinical features of, 574, 601–602 management in, 753
Eosinophilic granulomas, 201 obstruction of diagnosis of, 574, 574f, 602 magnetic resonance imaging of, 750f
Eosinophilic inflammation, 305 description of, 392–393, 393b etiology of, 573, 573b prognosis for, 753
Eosinophilic lung disease, 348–349 foreign objects as cause of, 458–459, pathogenesis of, 573 radiation therapy for, 753
Eosinophilic pneumonitis, 201 458f prognosis of, 602–603 treatment of, 753
Eosinophilic pulmonary granulomatosis, vascular ring anomalies as cause of, treatment of, 574, 602–603 Feline bartonellosis, 1458–1460, 1458f,
348 456, 457f ultrasonography of, 574f 1540–1541
Eosinophilic splenitis, 1412t perforation of, 416–417 Extramedullary hematopoiesis, 1413 Feline biliary tract disease, 567–573
Ephedrine, 1034t–1036t sarcomas of, 460 Extranodal lymphoma, 1294, 1296t, 1307 biliary cysts, 575
Epididymal abscess, 1001f Estriol, 733t–734t Extraocular muscles, 1058f, 1086 cholangitis, 567–573
Epididymis, 1000–1001, 1000f–1001f Estrogen Extraocular myositis, 1175–1176, 1175f neutrophilic, 568t, 569f
Epigastric pain, 635 ovulation and, 940–942 Extrathoracic airway obstruction, 271, sclerosing, 572
Epilepsy pregnancy termination using, 959 272f, 380–381, 381f cholecystitis, 573
definition of, 1093 Estrous cycle Extravascular hemolysis, 1231, Feline bronchitis, 328–333
idiopathic, 1094, 1105 in bitch 1346–1348 bronchodilators for, 332
scar tissue-related acquired, abnormalities of, 954–958 Extrinsic pathway, of coagulation classification of, 330b
1096–1097 description of, 937–940, 938t cascade, 221–222, 1387 clinical features of, 330
Epimastigotes, 1526 variations of, 953–954 Exudate, pathogenesis of, 522 diagnosis of, 330–331
Epistaxis, 240, 241b feline, 948–949 Exudative pericardial effusion, 177 differential diagnosis of, 329t
Epithelial cells, 666–667, 667f identification of, 940–945 Eye(s) doxycycline for, 332–333
Epithelial tissue, 1258–1259 manipulation of, 958–960 blastomycosis and, 1502 emergency stabilization of, 331
Epitheliotropic intestinal lymphoma, prevention of, 958 hypertension effects on, 212, 213b environmental considerations, 331
1296f, 1309 in queen, 948–949 lymphoma of, 1296, 1309 etiology of, 328–330
Epsilon-aminocaproic acid, 1394 Estrumate. see Cloprostenol F failure to respond to therapy, 333,
Epsiprantel, 444t, 515t–517t Estrus 333b
Epulides, 447 canine Facial deformity, 245–246, 245f glucocorticoids for, 331–332
Epulis, 448t description of, 937–939, 938t, Facial nerves metered-dose inhaler for drug
Equine chorionic gonadotropin, 959 939f–940f description of, 1056t, 1060f administration in, 327–328, 332f
Erection, canine, 995, 995f induction of, 958–959 evaluation of, 1059, 1060f physical examination of, 330
Erosive immune mediated polyarthritis, prolonged, 954–955, 954f paralysis of, 1160, 1160f–1161f prognosis of, 333
1208 dopamine agonists for inducement of, Factor Xa inhibitors, 229 small airway obstruction in, 328–330,
Erosive polyarthritis, 1189, 1208, 1245t 958–959 Factor XII, 1387 329b
Erythrocytes, in Greyhounds, 1360–1361 feline Fading neonates, 1021–1022, thoracic radiographs in, 330
Erythrocytosis, 1368–1370 description of, 944, 945f 1021f–1022f Feline calicivirus (FCV), 1453
classification of, 1368–1370, 1369b induction of, 959 Fading puppy syndrome, 1399 description of, 257
clinicopathologic findings, 1368–1369 suppression, 1034t–1036t False pregnancy, 1034t–1036t vaccines for, 258–259
definition of, 1368–1370 Ethyl alcohol, myocardial depression Familial Chinese Shar-Pei fever, 1205, Feline chronic progressive polyarthritis,
diagnosis of, 1369–1370, 1370f caused by, 150–151 1245t 1245t
hydroxyurea for, 116 Ethylene glycol intoxication/poisoning, Familial Mediterranean fever (FMF), Feline chronic rhinosinusitis, 266–268
phlebotomy for, 116, 1369 671, 690, 1099b 683–684 antibiotics for, 267–268
primary, 1368, 1369b Etodolac (Etogesic), 1197t, 1209t–1210t Familial polyarthritis, 1205 clinical features of, 267